Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 1999; 81(04): 664-665
DOI: 10.1055/s-0037-1614547
DOI: 10.1055/s-0037-1614547
Letters to the Editor
Increased Heart Rate and Haemostatic Balance Disorders Pre-exist the Established Hypertension
Further Information
Publication History
Publication Date:
09 December 2017 (online)
-
References
- 1 Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease. J Int Med 1990; 227: 273-8.
- 2 Makris Th Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J, Votteas V, Mandalaki T. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1998; 88: 99-107.
- 3 Lip GH, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80: 1566-71.
- 4 Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD. Haemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscl Thromb Vasc Biol 1997; 17: 3321-5.
- 5 Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 11: 519-27.
- 6 Giblum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease and death. The NHANES I Epidemiologic Follow up study. Am Heart J 1991; 121: 172-177.
- 7 Nordrehaug Mo R, Omrik P, Lung-Johansen P. The Bergen blood pressure study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Pressure 1995; 4: 16-22.
- 8 Endre T, Mattiason I, Berntorp E, Berglud G, Hulthen U. Coagulation and fibrinolytic factors in normotensive hypertension-prone men. J Hypertens 1996; 14: 629-34.
- 9 Lee AJ, Lowe GD, Woodward M, Pedro HT. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease and family history: the Scottish Heart Health Study. Br Heart J 1995; 69: 338-42.
- 10 Henry M, Tregonet DA, Alesi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan Vague I. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscl Thromb Vasc Biol 1998; 18: 84-91.